[Modern lipid-lowering drugs-A means to counter the problem of undertreatment?]
Innere Medizin (Heidelberg, Germany)(2022)
摘要
Using established and novel LDL-C-lowering drugs, the recommended LDL‑C target values can be achieved in the majority of patients with a high cardiovascular risk.
更多查看译文
关键词
Bempedoic acid,Cholesterol, LDL,Hydroxymethylglutaryl-CoA reductase inhibitors,Inclisiran,PCSK9 inhibitors
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要